WORKSHOP: The Science of ECP in Transplantation

Around 25% of organ transplant recipients encounter acute rejection within the first year post-transplantation. Acute rejection is further categorised into cellular (ACR) and antibody-mediated (AMR) forms. Over the long term, the threat shifts to chronic rejection, which poses a significant risk to graft function and patient survival.

Finding a balance between the beneficial and adverse effects of immunosuppression in preventing or treating rejection remains challenging. Factors such as opportunistic infections and malignancies further complicate this issue. Consequently, there is a keen interest in therapies that can effectively modulate alloimmune responses without suppressing the immune system’s ability to fight infection or malignancy.

Extracorporeal photopheresis (ECP) is used for various indications in solid organ transplant recipients. This workshop aims to highlight the current state-of-the-art of ECP and to address current evidence, barriers, and gaps in the use of ECP after solid organ transplantation.

PLEASE NOTE: This workshop will be conducted in Spanish

Programme (in Spanish):

• Welcome and introduction – Fritz Diekmann, Spain
• ECP in experimental kidney transplantation: What can we learn from a kidney transplant rat model? – Dr. Jordi Rovira, Spain
• ECP after kidney transplantation in immunologically high-risk patients – Dr. Carolt Arana, Spain
• Is there a place for ECP in BK virus nephropathy? – Dr. Ángela González Rojas, Spain
• Open Q&A and discussion – Full Panel
• Wrap-up and conclusions – Fritz Diekmann, Spain

Please fill out the Workshop Registration to get an email for your direct access link.

DISCLAIMER: This workshop is possible thanks to the unrestricted grant support from

 Physicians, Scientists, Allied Health Care Professionals, Nurses, Patients